APRIL ASHBY: Open Payments
NPI 1710606207 · GREENVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 20 payments from 13 companies in 2025. Trend: 2023 $190 · 2024 $263 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: VRAYLAR, Kerendia, MOUNJARO, REXULTI, FANAPT, INGREZZA, QULIPTA, Rybelsus.
Industry payments across KY — which companies pay providers there.
